Back to School: How biopharma can reboot drug development. Access exclusive analysis here
CEGE (Foster City, Calif.) published the design of its anti-HIV T cells in Blood, and showed that they kill
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury